Zárate E, Sá Rêgo M M, White P F, Duffy L, Shearer V E, Griffin J D, Whitten C W
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, 75235-9068, USA.
Anesthesiology. 1999 Apr;90(4):956-63. doi: 10.1097/00000542-199904000-00005.
Because adenosine has been alleged to produce both anesthetic and analgesic sparing effects, a randomized, double-blinded study was designed to compare the perioperative effects of adenosine and remifentanil when administered as intravenous adjuvants during general anesthesia for major gynecologic procedures.
Thirty-two women were assigned randomly to one of two drug treatment groups. After premedication with 0.04 mg/kg intravenous midazolam, anesthesia was induced with 2 micro/kg intravenous fentanyl, 1.5 mg/kg intravenous propofol, and 0.6 mg/kg intravenous rocuronium, and maintained with desflurane, 2%, and nitrous oxide, 65%, in oxygen. Before skin incision, an infusion of either remifentanil (0.02 microg x kg(-1) x min(-1)) or adenosine (25 microg x kg(-1) x min(-1)) was started and subsequently titrated to maintain systolic blood pressure, heart rate, or both within 10-15% of the preincision values.
Adenosine and remifentanil infusions were effective anesthetic adjuvants during lower abdominal surgery. Use of adenosine (mean +/- SEM, 166+/-17 microg x kg(-1) x min(-1)) was associated with a significantly greater decrease in systolic blood pressure and higher heart rate values compared with remifentanil (mean +/- SEM, 0.2+/-0.03 microg kg(-1) x min(-1)). Total postoperative opioid analgesic use was 45% and 27% lower in the adenosine group at 0-2 h and 2-24 h after surgery, respectively.
Adjunctive use of a variable-rate infusion of adenosine during desflurane-nitrous oxide anesthesia was associated with acceptable hemodynamic stability during the intraoperative period. Compared with remifentanil, intraoperative use of adenosine was associated with a decreased requirement for opioid analgesics during the first 24 h after operation.
由于据称腺苷具有麻醉和镇痛节省效应,因此设计了一项随机双盲研究,以比较腺苷和瑞芬太尼在大型妇科手术全身麻醉期间作为静脉佐剂使用时的围手术期效果。
32名女性被随机分配到两个药物治疗组之一。在静脉注射0.04mg/kg咪达唑仑进行术前用药后,静脉注射2μg/kg芬太尼、1.5mg/kg丙泊酚和0.6mg/kg罗库溴铵诱导麻醉,并用2%地氟醚和65%氧化亚氮加氧气维持麻醉。在皮肤切开前,开始输注瑞芬太尼(0.02μg·kg⁻¹·min⁻¹)或腺苷(25μg·kg⁻¹·min⁻¹),随后进行滴定以将收缩压、心率或两者维持在切开前值的10% - 15%以内。
在腹部下部手术期间,腺苷和瑞芬太尼输注均为有效的麻醉佐剂。与瑞芬太尼(平均±标准误,0.2±0.03μg·kg⁻¹·min⁻¹)相比,使用腺苷(平均±标准误,166±17μg·kg⁻¹·min⁻¹)与收缩压显著更大幅度下降和更高心率值相关。术后0 - 2小时和术后2 - 24小时,腺苷组的术后阿片类镇痛药总用量分别降低了45%和27%。
在地氟醚 - 氧化亚氮麻醉期间辅助使用可变速率输注腺苷与术中可接受的血流动力学稳定性相关。与瑞芬太尼相比,术中使用腺苷与术后24小时内阿片类镇痛药需求减少相关。